Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Investing Cash Flow

-$237.10M

TTM · Period ending: · USD

BIO logo

BIO Investing Cash Flow

Latest reported-$237.10M
BIO TTM Cash from Investing (-$17.60M → -$237.10M)
High-resolution chart · PNG

BIO investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-237,100,000
-285,800,000
-189,700,000
-186,044,000
-198,680,000
-114,207,000
-160,200,000
-57,459,000
-11,323,000
47,588,000
20,208,000
-121,304,000
-200,223,000
-372,688,000
-1,218,356,000
-1,703,525,000
-1,696,456,000
-1,652,252,000
-784,438,000
-280,063,000
-107,859,000
-96,155,000
-60,250,000
-71,337,000
-272,100,000
-198,598,000
-208,889,000
-202,504,000
-122,104,000
-190,875,000
-186,978,000
-145,250,000
-130,555,000
-83,996,000
-175,572,000
-212,612,000
-251,227,000
-273,414,000
-213,880,000
-247,535,000
-221,341,000
-189,736,000
-166,869,000
-132,535,000
-151,811,000
-182,932,000
-190,511,000
-183,403,000
38,038,000
70,740,000
-1,972,000
-31,676,000
-310,532,000
-434,801,000
-412,804,000
-510,288,000
-462,175,000
-392,405,000
-383,413,000
-265,991,000
-271,439,000
-216,791,000
-216,512,000
-187,001,000
-208,331,000
-240,250,000
-175,952,000
-217,600,000
-164,724,000
-123,859,000
-146,107,000
-476,355,000
-270,600,000
-301,251,000
-254,429,000
66,353,000
-171,974,000
-204,127,000
-207,748,000
-125,920,000
-100,922,000
-91,820,000
-6,172,000
-110,784,000
-93,282,000
-17,004,000
-161,711,000
-94,206,000
-112,153,000
-137,088,000
-106,994,000
-90,693,000
-65,934,000
-66,600,000
-54,456,000
-52,993,000
-57,960,000
-47,962,000
-47,538,000
-36,130,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.